Buy Rating Affirmed for Star Equity Holdings Amid Strategic Acquisition and Positive Financial Outlook
Star Equity Holdings: Strong Sales Pipeline and Growth Prospects Support Buy Rating
Star Equity Holdings (STRR) Gets a Buy From Maxim Group
Star Equity Holdings (STRR) Gets a Buy From Maxim Group
Analysts Offer Insights on Healthcare Companies: Star Equity Holdings (STRR), Applied DNA Sciences (APDN) and Dermata Therapeutics (DRMA)
Star Equity Holdings (STRR) Gets a Buy From Maxim Group
Analysts Offer Insights on Healthcare Companies: Star Equity Holdings (STRR), Evelo Biosciences (EVLO) and 4D Molecular Therapeutics (FDMT)
Analysts Offer Insights on Healthcare Companies: Star Equity Holdings (STRR) and SCYNEXIS (SCYX)
No Data